Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of SGT-53 in Conjunction With Irradiation and Chemotherapy in Children With Recurrent or Progressive CNS Malignancies

NCT03554707 is registered in ClinicalTrials.gov with SynerGene Therapeutics, Inc. as lead sponsor.

NCT NCT03554707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03554707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of SGT-53 in Conjunction With Irradiation and Chemotherapy in Children With Recurrent or Progressive CNS Malignancies
Lead sponsor
SynerGene Therapeutics, Inc.
Phase
Phase 1
Overall status
Withdrawn
Start date
June 1, 2022
Completion date
June 1, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood cns tumor